nodes	percent_of_prediction	percent_of_DWPC	metapath
Palonosetron—CYP2D6—Vinorelbine—ovarian cancer	0.0969	0.255	CbGbCtD
Palonosetron—CYP3A4—Topotecan—ovarian cancer	0.0875	0.23	CbGbCtD
Palonosetron—CYP3A4—Vinorelbine—ovarian cancer	0.0616	0.162	CbGbCtD
Palonosetron—CYP3A4—Paclitaxel—ovarian cancer	0.0433	0.114	CbGbCtD
Palonosetron—CYP2D6—Doxorubicin—ovarian cancer	0.0367	0.0964	CbGbCtD
Palonosetron—CYP3A4—Docetaxel—ovarian cancer	0.0313	0.0822	CbGbCtD
Palonosetron—CYP3A4—Doxorubicin—ovarian cancer	0.0233	0.0613	CbGbCtD
Palonosetron—Menopausal symptoms—Doxorubicin—ovarian cancer	0.000778	0.00126	CcSEcCtD
Palonosetron—Anaemia—Paclitaxel—ovarian cancer	0.000772	0.00125	CcSEcCtD
Palonosetron—Eye disorder—Docetaxel—ovarian cancer	0.00076	0.00123	CcSEcCtD
Palonosetron—Anaphylactoid reaction—Doxorubicin—ovarian cancer	0.000758	0.00122	CcSEcCtD
Palonosetron—Cardiac disorder—Docetaxel—ovarian cancer	0.000755	0.00122	CcSEcCtD
Palonosetron—Vomiting—Topotecan—ovarian cancer	0.000754	0.00122	CcSEcCtD
Palonosetron—Rash—Topotecan—ovarian cancer	0.000747	0.00121	CcSEcCtD
Palonosetron—Hypersensitivity—Vinorelbine—ovarian cancer	0.000747	0.00121	CcSEcCtD
Palonosetron—Dermatitis—Topotecan—ovarian cancer	0.000747	0.00121	CcSEcCtD
Palonosetron—Headache—Topotecan—ovarian cancer	0.000742	0.0012	CcSEcCtD
Palonosetron—Angiopathy—Docetaxel—ovarian cancer	0.000738	0.00119	CcSEcCtD
Palonosetron—Vomiting—Melphalan—ovarian cancer	0.000738	0.00119	CcSEcCtD
Palonosetron—Immune system disorder—Docetaxel—ovarian cancer	0.000735	0.00119	CcSEcCtD
Palonosetron—Pain in extremity—Doxorubicin—ovarian cancer	0.000734	0.00119	CcSEcCtD
Palonosetron—Mediastinal disorder—Docetaxel—ovarian cancer	0.000733	0.00118	CcSEcCtD
Palonosetron—Rash—Melphalan—ovarian cancer	0.000732	0.00118	CcSEcCtD
Palonosetron—Dermatitis—Melphalan—ovarian cancer	0.000731	0.00118	CcSEcCtD
Palonosetron—Chills—Docetaxel—ovarian cancer	0.00073	0.00118	CcSEcCtD
Palonosetron—Asthenia—Vinorelbine—ovarian cancer	0.000727	0.00117	CcSEcCtD
Palonosetron—Arrhythmia—Docetaxel—ovarian cancer	0.000727	0.00117	CcSEcCtD
Palonosetron—Abdominal pain upper—Epirubicin—ovarian cancer	0.000724	0.00117	CcSEcCtD
Palonosetron—Convulsion—Paclitaxel—ovarian cancer	0.000724	0.00117	CcSEcCtD
Palonosetron—Hypokalaemia—Epirubicin—ovarian cancer	0.000722	0.00117	CcSEcCtD
Palonosetron—Hypertension—Paclitaxel—ovarian cancer	0.000721	0.00116	CcSEcCtD
Palonosetron—Alopecia—Docetaxel—ovarian cancer	0.000719	0.00116	CcSEcCtD
Palonosetron—Pruritus—Vinorelbine—ovarian cancer	0.000717	0.00116	CcSEcCtD
Palonosetron—Aspartate aminotransferase increased—Epirubicin—ovarian cancer	0.000714	0.00115	CcSEcCtD
Palonosetron—Mental disorder—Docetaxel—ovarian cancer	0.000713	0.00115	CcSEcCtD
Palonosetron—Myalgia—Paclitaxel—ovarian cancer	0.000711	0.00115	CcSEcCtD
Palonosetron—Arthralgia—Paclitaxel—ovarian cancer	0.000711	0.00115	CcSEcCtD
Palonosetron—Anxiety—Paclitaxel—ovarian cancer	0.000709	0.00114	CcSEcCtD
Palonosetron—Erythema—Docetaxel—ovarian cancer	0.000708	0.00114	CcSEcCtD
Palonosetron—Malnutrition—Docetaxel—ovarian cancer	0.000708	0.00114	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000706	0.00114	CcSEcCtD
Palonosetron—Nausea—Topotecan—ovarian cancer	0.000704	0.00114	CcSEcCtD
Palonosetron—Discomfort—Paclitaxel—ovarian cancer	0.000703	0.00113	CcSEcCtD
Palonosetron—Gastritis—Epirubicin—ovarian cancer	0.000702	0.00113	CcSEcCtD
Palonosetron—Dry mouth—Paclitaxel—ovarian cancer	0.000696	0.00112	CcSEcCtD
Palonosetron—Diarrhoea—Vinorelbine—ovarian cancer	0.000694	0.00112	CcSEcCtD
Palonosetron—Dysgeusia—Docetaxel—ovarian cancer	0.000694	0.00112	CcSEcCtD
Palonosetron—Abdominal distension—Epirubicin—ovarian cancer	0.00069	0.00111	CcSEcCtD
Palonosetron—Nausea—Melphalan—ovarian cancer	0.000689	0.00111	CcSEcCtD
Palonosetron—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000682	0.0011	CcSEcCtD
Palonosetron—Infection—Paclitaxel—ovarian cancer	0.000677	0.00109	CcSEcCtD
Palonosetron—Shock—Paclitaxel—ovarian cancer	0.000671	0.00108	CcSEcCtD
Palonosetron—Dizziness—Vinorelbine—ovarian cancer	0.00067	0.00108	CcSEcCtD
Palonosetron—Abdominal pain upper—Doxorubicin—ovarian cancer	0.00067	0.00108	CcSEcCtD
Palonosetron—Nervous system disorder—Paclitaxel—ovarian cancer	0.000669	0.00108	CcSEcCtD
Palonosetron—Hypokalaemia—Doxorubicin—ovarian cancer	0.000668	0.00108	CcSEcCtD
Palonosetron—Tachycardia—Paclitaxel—ovarian cancer	0.000666	0.00107	CcSEcCtD
Palonosetron—Skin disorder—Paclitaxel—ovarian cancer	0.000662	0.00107	CcSEcCtD
Palonosetron—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	0.000661	0.00107	CcSEcCtD
Palonosetron—Anaemia—Docetaxel—ovarian cancer	0.000655	0.00106	CcSEcCtD
Palonosetron—Anorexia—Paclitaxel—ovarian cancer	0.00065	0.00105	CcSEcCtD
Palonosetron—Gastritis—Doxorubicin—ovarian cancer	0.00065	0.00105	CcSEcCtD
Palonosetron—Vomiting—Vinorelbine—ovarian cancer	0.000645	0.00104	CcSEcCtD
Palonosetron—Rash—Vinorelbine—ovarian cancer	0.000639	0.00103	CcSEcCtD
Palonosetron—Dermatitis—Vinorelbine—ovarian cancer	0.000639	0.00103	CcSEcCtD
Palonosetron—Abdominal distension—Doxorubicin—ovarian cancer	0.000639	0.00103	CcSEcCtD
Palonosetron—Hypotension—Paclitaxel—ovarian cancer	0.000637	0.00103	CcSEcCtD
Palonosetron—Headache—Vinorelbine—ovarian cancer	0.000635	0.00103	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000621	0.001	CcSEcCtD
Palonosetron—Hyperglycaemia—Epirubicin—ovarian cancer	0.000618	0.000999	CcSEcCtD
Palonosetron—Insomnia—Paclitaxel—ovarian cancer	0.000617	0.000996	CcSEcCtD
Palonosetron—Convulsion—Docetaxel—ovarian cancer	0.000614	0.000991	CcSEcCtD
Palonosetron—Paraesthesia—Paclitaxel—ovarian cancer	0.000612	0.000989	CcSEcCtD
Palonosetron—Hypertension—Docetaxel—ovarian cancer	0.000611	0.000987	CcSEcCtD
Palonosetron—Dyspnoea—Paclitaxel—ovarian cancer	0.000608	0.000982	CcSEcCtD
Palonosetron—Somnolence—Paclitaxel—ovarian cancer	0.000606	0.000979	CcSEcCtD
Palonosetron—Arthralgia—Docetaxel—ovarian cancer	0.000603	0.000974	CcSEcCtD
Palonosetron—Myalgia—Docetaxel—ovarian cancer	0.000603	0.000974	CcSEcCtD
Palonosetron—Nausea—Vinorelbine—ovarian cancer	0.000602	0.000972	CcSEcCtD
Palonosetron—Dyspepsia—Paclitaxel—ovarian cancer	0.0006	0.000969	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000599	0.000967	CcSEcCtD
Palonosetron—Decreased appetite—Paclitaxel—ovarian cancer	0.000593	0.000957	CcSEcCtD
Palonosetron—Dry mouth—Docetaxel—ovarian cancer	0.00059	0.000952	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000589	0.000951	CcSEcCtD
Palonosetron—Fatigue—Paclitaxel—ovarian cancer	0.000588	0.000949	CcSEcCtD
Palonosetron—Constipation—Paclitaxel—ovarian cancer	0.000583	0.000942	CcSEcCtD
Palonosetron—Pain—Paclitaxel—ovarian cancer	0.000583	0.000942	CcSEcCtD
Palonosetron—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000578	0.000934	CcSEcCtD
Palonosetron—Anaphylactic shock—Docetaxel—ovarian cancer	0.000578	0.000933	CcSEcCtD
Palonosetron—Epistaxis—Epirubicin—ovarian cancer	0.000577	0.000931	CcSEcCtD
Palonosetron—Infection—Docetaxel—ovarian cancer	0.000574	0.000927	CcSEcCtD
Palonosetron—Sinusitis—Epirubicin—ovarian cancer	0.000573	0.000926	CcSEcCtD
Palonosetron—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000572	0.000924	CcSEcCtD
Palonosetron—Shock—Docetaxel—ovarian cancer	0.000569	0.000918	CcSEcCtD
Palonosetron—Nervous system disorder—Docetaxel—ovarian cancer	0.000567	0.000915	CcSEcCtD
Palonosetron—Tachycardia—Docetaxel—ovarian cancer	0.000564	0.000911	CcSEcCtD
Palonosetron—Skin disorder—Docetaxel—ovarian cancer	0.000561	0.000907	CcSEcCtD
Palonosetron—Bradycardia—Epirubicin—ovarian cancer	0.000559	0.000902	CcSEcCtD
Palonosetron—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000558	0.0009	CcSEcCtD
Palonosetron—Anorexia—Docetaxel—ovarian cancer	0.000551	0.00089	CcSEcCtD
Palonosetron—Urinary tract disorder—Epirubicin—ovarian cancer	0.000542	0.000875	CcSEcCtD
Palonosetron—Hypotension—Docetaxel—ovarian cancer	0.00054	0.000872	CcSEcCtD
Palonosetron—Connective tissue disorder—Epirubicin—ovarian cancer	0.000539	0.000871	CcSEcCtD
Palonosetron—Abdominal pain—Paclitaxel—ovarian cancer	0.000539	0.000871	CcSEcCtD
Palonosetron—Body temperature increased—Paclitaxel—ovarian cancer	0.000539	0.000871	CcSEcCtD
Palonosetron—Urethral disorder—Epirubicin—ovarian cancer	0.000538	0.000869	CcSEcCtD
Palonosetron—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000535	0.000864	CcSEcCtD
Palonosetron—Epistaxis—Doxorubicin—ovarian cancer	0.000533	0.000862	CcSEcCtD
Palonosetron—Sinusitis—Doxorubicin—ovarian cancer	0.000531	0.000857	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000527	0.00085	CcSEcCtD
Palonosetron—Insomnia—Docetaxel—ovarian cancer	0.000523	0.000844	CcSEcCtD
Palonosetron—Paraesthesia—Docetaxel—ovarian cancer	0.000519	0.000838	CcSEcCtD
Palonosetron—Bradycardia—Doxorubicin—ovarian cancer	0.000517	0.000835	CcSEcCtD
Palonosetron—Dyspnoea—Docetaxel—ovarian cancer	0.000515	0.000832	CcSEcCtD
Palonosetron—Somnolence—Docetaxel—ovarian cancer	0.000514	0.00083	CcSEcCtD
Palonosetron—Eye disorder—Epirubicin—ovarian cancer	0.000513	0.000828	CcSEcCtD
Palonosetron—Tinnitus—Epirubicin—ovarian cancer	0.000512	0.000826	CcSEcCtD
Palonosetron—Cardiac disorder—Epirubicin—ovarian cancer	0.000509	0.000822	CcSEcCtD
Palonosetron—Dyspepsia—Docetaxel—ovarian cancer	0.000509	0.000822	CcSEcCtD
Palonosetron—Decreased appetite—Docetaxel—ovarian cancer	0.000502	0.000811	CcSEcCtD
Palonosetron—Hypersensitivity—Paclitaxel—ovarian cancer	0.000502	0.000811	CcSEcCtD
Palonosetron—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000501	0.00081	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000499	0.000806	CcSEcCtD
Palonosetron—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000499	0.000806	CcSEcCtD
Palonosetron—Fatigue—Docetaxel—ovarian cancer	0.000498	0.000805	CcSEcCtD
Palonosetron—Angiopathy—Epirubicin—ovarian cancer	0.000498	0.000804	CcSEcCtD
Palonosetron—Urethral disorder—Doxorubicin—ovarian cancer	0.000498	0.000804	CcSEcCtD
Palonosetron—Immune system disorder—Epirubicin—ovarian cancer	0.000496	0.0008	CcSEcCtD
Palonosetron—Mediastinal disorder—Epirubicin—ovarian cancer	0.000495	0.000799	CcSEcCtD
Palonosetron—Pain—Docetaxel—ovarian cancer	0.000494	0.000798	CcSEcCtD
Palonosetron—Constipation—Docetaxel—ovarian cancer	0.000494	0.000798	CcSEcCtD
Palonosetron—Chills—Epirubicin—ovarian cancer	0.000492	0.000795	CcSEcCtD
Palonosetron—Arrhythmia—Epirubicin—ovarian cancer	0.00049	0.000792	CcSEcCtD
Palonosetron—Asthenia—Paclitaxel—ovarian cancer	0.000489	0.00079	CcSEcCtD
Palonosetron—Alopecia—Epirubicin—ovarian cancer	0.000485	0.000783	CcSEcCtD
Palonosetron—Pruritus—Paclitaxel—ovarian cancer	0.000482	0.000779	CcSEcCtD
Palonosetron—Mental disorder—Epirubicin—ovarian cancer	0.000481	0.000776	CcSEcCtD
Palonosetron—Erythema—Epirubicin—ovarian cancer	0.000478	0.000771	CcSEcCtD
Palonosetron—Malnutrition—Epirubicin—ovarian cancer	0.000478	0.000771	CcSEcCtD
Palonosetron—Eye disorder—Doxorubicin—ovarian cancer	0.000475	0.000766	CcSEcCtD
Palonosetron—Tinnitus—Doxorubicin—ovarian cancer	0.000473	0.000764	CcSEcCtD
Palonosetron—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000473	0.000763	CcSEcCtD
Palonosetron—Cardiac disorder—Doxorubicin—ovarian cancer	0.000471	0.000761	CcSEcCtD
Palonosetron—Flatulence—Epirubicin—ovarian cancer	0.000471	0.00076	CcSEcCtD
Palonosetron—Dysgeusia—Epirubicin—ovarian cancer	0.000468	0.000755	CcSEcCtD
Palonosetron—Diarrhoea—Paclitaxel—ovarian cancer	0.000467	0.000753	CcSEcCtD
Palonosetron—Angiopathy—Doxorubicin—ovarian cancer	0.000461	0.000744	CcSEcCtD
Palonosetron—Immune system disorder—Doxorubicin—ovarian cancer	0.000459	0.000741	CcSEcCtD
Palonosetron—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000458	0.000739	CcSEcCtD
Palonosetron—Abdominal pain—Docetaxel—ovarian cancer	0.000457	0.000738	CcSEcCtD
Palonosetron—Body temperature increased—Docetaxel—ovarian cancer	0.000457	0.000738	CcSEcCtD
Palonosetron—Chills—Doxorubicin—ovarian cancer	0.000456	0.000736	CcSEcCtD
Palonosetron—Arrhythmia—Doxorubicin—ovarian cancer	0.000454	0.000732	CcSEcCtD
Palonosetron—Dizziness—Paclitaxel—ovarian cancer	0.000451	0.000728	CcSEcCtD
Palonosetron—Alopecia—Doxorubicin—ovarian cancer	0.000449	0.000725	CcSEcCtD
Palonosetron—Mental disorder—Doxorubicin—ovarian cancer	0.000445	0.000718	CcSEcCtD
Palonosetron—Erythema—Doxorubicin—ovarian cancer	0.000442	0.000714	CcSEcCtD
Palonosetron—Malnutrition—Doxorubicin—ovarian cancer	0.000442	0.000714	CcSEcCtD
Palonosetron—Anaemia—Epirubicin—ovarian cancer	0.000442	0.000713	CcSEcCtD
Palonosetron—Flatulence—Doxorubicin—ovarian cancer	0.000436	0.000703	CcSEcCtD
Palonosetron—Vomiting—Paclitaxel—ovarian cancer	0.000434	0.0007	CcSEcCtD
Palonosetron—Dysgeusia—Doxorubicin—ovarian cancer	0.000433	0.000699	CcSEcCtD
Palonosetron—Rash—Paclitaxel—ovarian cancer	0.00043	0.000694	CcSEcCtD
Palonosetron—Dermatitis—Paclitaxel—ovarian cancer	0.00043	0.000694	CcSEcCtD
Palonosetron—Headache—Paclitaxel—ovarian cancer	0.000427	0.00069	CcSEcCtD
Palonosetron—Hypersensitivity—Docetaxel—ovarian cancer	0.000426	0.000688	CcSEcCtD
Palonosetron—Asthenia—Docetaxel—ovarian cancer	0.000415	0.00067	CcSEcCtD
Palonosetron—Convulsion—Epirubicin—ovarian cancer	0.000414	0.000668	CcSEcCtD
Palonosetron—Hypertension—Epirubicin—ovarian cancer	0.000412	0.000666	CcSEcCtD
Palonosetron—Pruritus—Docetaxel—ovarian cancer	0.000409	0.00066	CcSEcCtD
Palonosetron—Anaemia—Doxorubicin—ovarian cancer	0.000409	0.00066	CcSEcCtD
Palonosetron—Myalgia—Epirubicin—ovarian cancer	0.000407	0.000657	CcSEcCtD
Palonosetron—Arthralgia—Epirubicin—ovarian cancer	0.000407	0.000657	CcSEcCtD
Palonosetron—Anxiety—Epirubicin—ovarian cancer	0.000405	0.000654	CcSEcCtD
Palonosetron—Nausea—Paclitaxel—ovarian cancer	0.000405	0.000654	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000404	0.000652	CcSEcCtD
Palonosetron—Discomfort—Epirubicin—ovarian cancer	0.000402	0.000649	CcSEcCtD
Palonosetron—Dry mouth—Epirubicin—ovarian cancer	0.000398	0.000642	CcSEcCtD
Palonosetron—Diarrhoea—Docetaxel—ovarian cancer	0.000395	0.000639	CcSEcCtD
Palonosetron—Anaphylactic shock—Epirubicin—ovarian cancer	0.00039	0.00063	CcSEcCtD
Palonosetron—Infection—Epirubicin—ovarian cancer	0.000387	0.000625	CcSEcCtD
Palonosetron—Shock—Epirubicin—ovarian cancer	0.000384	0.000619	CcSEcCtD
Palonosetron—Convulsion—Doxorubicin—ovarian cancer	0.000383	0.000618	CcSEcCtD
Palonosetron—Nervous system disorder—Epirubicin—ovarian cancer	0.000382	0.000617	CcSEcCtD
Palonosetron—Dizziness—Docetaxel—ovarian cancer	0.000382	0.000617	CcSEcCtD
Palonosetron—Hypertension—Doxorubicin—ovarian cancer	0.000382	0.000616	CcSEcCtD
Palonosetron—Tachycardia—Epirubicin—ovarian cancer	0.000381	0.000614	CcSEcCtD
Palonosetron—Skin disorder—Epirubicin—ovarian cancer	0.000379	0.000612	CcSEcCtD
Palonosetron—Arthralgia—Doxorubicin—ovarian cancer	0.000376	0.000608	CcSEcCtD
Palonosetron—Myalgia—Doxorubicin—ovarian cancer	0.000376	0.000608	CcSEcCtD
Palonosetron—Anxiety—Doxorubicin—ovarian cancer	0.000375	0.000606	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000374	0.000603	CcSEcCtD
Palonosetron—Discomfort—Doxorubicin—ovarian cancer	0.000372	0.0006	CcSEcCtD
Palonosetron—Anorexia—Epirubicin—ovarian cancer	0.000372	0.0006	CcSEcCtD
Palonosetron—Dry mouth—Doxorubicin—ovarian cancer	0.000368	0.000594	CcSEcCtD
Palonosetron—Vomiting—Docetaxel—ovarian cancer	0.000368	0.000593	CcSEcCtD
Palonosetron—Rash—Docetaxel—ovarian cancer	0.000364	0.000589	CcSEcCtD
Palonosetron—Hypotension—Epirubicin—ovarian cancer	0.000364	0.000588	CcSEcCtD
Palonosetron—Dermatitis—Docetaxel—ovarian cancer	0.000364	0.000588	CcSEcCtD
Palonosetron—Headache—Docetaxel—ovarian cancer	0.000362	0.000585	CcSEcCtD
Palonosetron—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000361	0.000583	CcSEcCtD
Palonosetron—Infection—Doxorubicin—ovarian cancer	0.000358	0.000579	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000355	0.000574	CcSEcCtD
Palonosetron—Shock—Doxorubicin—ovarian cancer	0.000355	0.000573	CcSEcCtD
Palonosetron—Nervous system disorder—Doxorubicin—ovarian cancer	0.000354	0.000571	CcSEcCtD
Palonosetron—Insomnia—Epirubicin—ovarian cancer	0.000353	0.000569	CcSEcCtD
Palonosetron—Tachycardia—Doxorubicin—ovarian cancer	0.000352	0.000569	CcSEcCtD
Palonosetron—Skin disorder—Doxorubicin—ovarian cancer	0.00035	0.000566	CcSEcCtD
Palonosetron—Paraesthesia—Epirubicin—ovarian cancer	0.00035	0.000565	CcSEcCtD
Palonosetron—Dyspnoea—Epirubicin—ovarian cancer	0.000348	0.000561	CcSEcCtD
Palonosetron—Somnolence—Epirubicin—ovarian cancer	0.000347	0.00056	CcSEcCtD
Palonosetron—Anorexia—Doxorubicin—ovarian cancer	0.000344	0.000555	CcSEcCtD
Palonosetron—Nausea—Docetaxel—ovarian cancer	0.000343	0.000554	CcSEcCtD
Palonosetron—Dyspepsia—Epirubicin—ovarian cancer	0.000343	0.000554	CcSEcCtD
Palonosetron—Decreased appetite—Epirubicin—ovarian cancer	0.000339	0.000547	CcSEcCtD
Palonosetron—Hypotension—Doxorubicin—ovarian cancer	0.000337	0.000544	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000337	0.000544	CcSEcCtD
Palonosetron—Fatigue—Epirubicin—ovarian cancer	0.000336	0.000543	CcSEcCtD
Palonosetron—Pain—Epirubicin—ovarian cancer	0.000333	0.000538	CcSEcCtD
Palonosetron—Constipation—Epirubicin—ovarian cancer	0.000333	0.000538	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000329	0.000531	CcSEcCtD
Palonosetron—Insomnia—Doxorubicin—ovarian cancer	0.000326	0.000527	CcSEcCtD
Palonosetron—Paraesthesia—Doxorubicin—ovarian cancer	0.000324	0.000523	CcSEcCtD
Palonosetron—Dyspnoea—Doxorubicin—ovarian cancer	0.000322	0.000519	CcSEcCtD
Palonosetron—Somnolence—Doxorubicin—ovarian cancer	0.000321	0.000518	CcSEcCtD
Palonosetron—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000319	0.000515	CcSEcCtD
Palonosetron—Dyspepsia—Doxorubicin—ovarian cancer	0.000318	0.000513	CcSEcCtD
Palonosetron—Decreased appetite—Doxorubicin—ovarian cancer	0.000314	0.000506	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000311	0.000503	CcSEcCtD
Palonosetron—Fatigue—Doxorubicin—ovarian cancer	0.000311	0.000502	CcSEcCtD
Palonosetron—Pain—Doxorubicin—ovarian cancer	0.000308	0.000498	CcSEcCtD
Palonosetron—Constipation—Doxorubicin—ovarian cancer	0.000308	0.000498	CcSEcCtD
Palonosetron—Abdominal pain—Epirubicin—ovarian cancer	0.000308	0.000498	CcSEcCtD
Palonosetron—Body temperature increased—Epirubicin—ovarian cancer	0.000308	0.000498	CcSEcCtD
Palonosetron—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000295	0.000476	CcSEcCtD
Palonosetron—Hypersensitivity—Epirubicin—ovarian cancer	0.000287	0.000464	CcSEcCtD
Palonosetron—Body temperature increased—Doxorubicin—ovarian cancer	0.000285	0.000461	CcSEcCtD
Palonosetron—Abdominal pain—Doxorubicin—ovarian cancer	0.000285	0.000461	CcSEcCtD
Palonosetron—Asthenia—Epirubicin—ovarian cancer	0.00028	0.000452	CcSEcCtD
Palonosetron—Pruritus—Epirubicin—ovarian cancer	0.000276	0.000445	CcSEcCtD
Palonosetron—Diarrhoea—Epirubicin—ovarian cancer	0.000267	0.000431	CcSEcCtD
Palonosetron—Hypersensitivity—Doxorubicin—ovarian cancer	0.000266	0.000429	CcSEcCtD
Palonosetron—Asthenia—Doxorubicin—ovarian cancer	0.000259	0.000418	CcSEcCtD
Palonosetron—Dizziness—Epirubicin—ovarian cancer	0.000258	0.000416	CcSEcCtD
Palonosetron—Pruritus—Doxorubicin—ovarian cancer	0.000255	0.000412	CcSEcCtD
Palonosetron—Vomiting—Epirubicin—ovarian cancer	0.000248	0.0004	CcSEcCtD
Palonosetron—Diarrhoea—Doxorubicin—ovarian cancer	0.000247	0.000399	CcSEcCtD
Palonosetron—Rash—Epirubicin—ovarian cancer	0.000246	0.000397	CcSEcCtD
Palonosetron—Dermatitis—Epirubicin—ovarian cancer	0.000246	0.000397	CcSEcCtD
Palonosetron—Headache—Epirubicin—ovarian cancer	0.000244	0.000394	CcSEcCtD
Palonosetron—Dizziness—Doxorubicin—ovarian cancer	0.000239	0.000385	CcSEcCtD
Palonosetron—Nausea—Epirubicin—ovarian cancer	0.000232	0.000374	CcSEcCtD
Palonosetron—Vomiting—Doxorubicin—ovarian cancer	0.000229	0.00037	CcSEcCtD
Palonosetron—Rash—Doxorubicin—ovarian cancer	0.000227	0.000367	CcSEcCtD
Palonosetron—Dermatitis—Doxorubicin—ovarian cancer	0.000227	0.000367	CcSEcCtD
Palonosetron—Headache—Doxorubicin—ovarian cancer	0.000226	0.000365	CcSEcCtD
Palonosetron—Nausea—Doxorubicin—ovarian cancer	0.000214	0.000346	CcSEcCtD
